IA
AMPH icon

IndexIQ Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

IndexIQ Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$413K Buy
+11,499
New +$326K 0.01% 500

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IndexIQ Advisors's AMPH Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2022: 11,499 shares worth $413K. The stake represents 0.01% of the portfolio and ranks #500 among its holdings.

203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

  • IndexIQ Advisors held 11,499 shares of Amphastar Pharmaceuticals worth $413K as of Q1 2022.
  • Amphastar Pharmaceuticals was a new IndexIQ Advisors position in Q1 2022.
  • Amphastar Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #500 holding.
  • 203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.